Contribution of periodontal health in cardiovascular secondary prevention: Analyses on hospitalized patients in cardiology units

被引:2
|
作者
Hamaya, Rikuta [1 ,2 ,3 ,8 ]
Yonetsu, Taishi [4 ,9 ]
Aoyama, Norio [5 ]
Shiheido-Watanabe, Yuka [6 ]
Tashiro, Akira [4 ]
Niida, Takayuki [4 ]
Isobe, Mitsuaki [7 ]
Maejima, Yasuhiro [4 ]
Iwata, Takanori [6 ]
Sasano, Tetsuo [4 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[4] Tokyo Med & Dent Univ, Dept Cardiol, Tokyo, Japan
[5] Kanagawa Dent Univ, Dept Periodontol, Yokosuka, Kanagawa, Japan
[6] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan
[7] Sakakibara Heart Inst, Dept Cardiol, Tokyo, Japan
[8] Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA
[9] Tokyo Med & Dent Univ, Dept Cardiovasc Med, 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138510, Japan
关键词
dental health; periodontitis; secondary cardiovascular prevention; MYOCARDIAL-INFARCTION; DENTAL-CARIES; DISEASE; EVENTS; STROKE; RISK; ASSOCIATION; TEETH;
D O I
10.1111/jcpe.13792
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Aim: To investigate the association between dental health and incident cardiovascular disease (CVD) in secondary prevention setting.Materials and Methods: A total of 888 patients with known CVD hospitalized in the cardiology unit were prospectively enrolled. We assessed the association between missing teeth and three variables of periodontitis and major adverse cardiovascular events (MACE), defined as a composite of cardiac death, acute myocardial infarction, stroke and hospital re-admission for congestive heart failure.Results: During a median (Q1, Q3) follow-up of 4.6 (1.4, 6.7) years, an additional missing tooth was associated with a 3% (95% confidence interval [CI]: 1%-5%) higher hazard of MACE (p = .004). Compared with patients with 0 to <= 4 missing teeth, periods free from MACE (95% CI) by 5 years of follow-up were, on average, shorter by 0.17 (-0.04 to 0.37) years, 0.26 (0.04-0.49) years and 0.59 (0.34-0.85) years in patients with 5 to <= 7, 8 to <= 13 and > 13 missing teeth, respectively. No significant associations were observed between periodontal measures and MACE incidence.Conclusions: In hospitalized patients with existing CVD, the total number of missing teeth was associated with incident MACE.
引用
收藏
页码:708 / 716
页数:9
相关论文
共 50 条
  • [21] Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?
    Poredos, Pavel
    Jezovnik, Mateja Kaja
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (07) : 14477 - 14489
  • [22] Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study
    Jakobsson, Stina
    Irewall, Anna-Lotta
    Bjorklund, Fredrik
    Mooe, Thomas
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [23] Effect of Gender, Caregiver, on Cholesterol Control and Statin Use for Secondary Prevention Among Hospitalized Patients With Coronary Heart Disease
    Hammond, Gmerice
    Mochari-Greenberger, Heidi
    Liao, Ming
    Mosca, Lori
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11) : 1613 - 1618
  • [24] Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study
    Stina Jakobsson
    Anna-Lotta Irewall
    Fredrik Bjorklund
    Thomas Mooe
    BMC Cardiovascular Disorders, 15
  • [25] Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery
    Werba, Jose Pablo
    Bonomi, Alice
    Giroli, Monica
    Amato, Manuela
    Vigo, Lorenzo
    Agrifoglio, Marco
    Alamanni, Francesco
    Cavallotti, Laura
    Kassem, Samer
    Naliato, Moreno
    Parolari, Alessandro
    Penza, Eleonora
    Polvani, Gianluca
    Pompilio, Giulio
    Porqueddu, Massimo
    Roberto, Maurizio
    Salis, Stefano
    Zanobini, Marco
    Amato, Mauro
    Baldassarre, Damiano
    Veglia, Fabrizio
    Tremoli, Elena
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (07) : 997 - 1004
  • [26] Technological Interventions to Implement Prevention and Health Promotion in Cardiovascular Patients
    Bashir, Ayisha Z.
    Yetman, Anji
    Wehrmann, Melissa
    HEALTHCARE, 2024, 12 (20)
  • [27] Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study
    Cosin-Sales, Juan
    Murcia-Zaragoza, Jose M.
    Pereyra-Rico, Hector O.
    de la Guia-Galipienso, Fernando
    Hermans, Kurt
    Rubio, Gabriel
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (13) : 975 - 985
  • [28] ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation
    Sobhy, Mohamed
    Eletriby, Adel
    Ragy, Hany
    Kandil, Hossam
    Saleh, Mohamed Ayman
    Farag, Nabil
    Guindy, Ramez
    Bendary, Ahmed
    Nayel, Ahmed Mohamed Elmahmoudy
    Shawky, Ahmed
    Khairy, Ayman
    Mortada, Ayman
    Zarif, Bassem
    Badran, Haitham
    Khorshid, Hazem
    Mahmoud, Kareem
    Said, Karim
    Leon, Khaled
    Abdelsabour, Mahmoud
    Tawfik, Mazen
    Abdelmegid, Mohamed Aboel-Kassem F.
    Koriem, Mohamed
    Loutfi, Mohamed
    Wadie, Moheb
    Elnoamany, Mohamed
    Sadaka, Mohamed
    Seleem, Mohamed
    Zahran, Mohamed
    Amin, Osama A.
    Elkaffas, Sameh
    Ayad, Sherif
    Kilany, Wael El
    Ammar, Walid
    Elawady, Waleed
    Elhammady, Walid
    Abdelhady, Yasser
    CARDIOLOGY AND THERAPY, 2024, 13 (04) : 707 - 736
  • [29] Diagnosis and secondary prevention measures in patients hospitalized for cerebral infarction in Spain. The DIAPRESIC study
    Gil-Nunez, Antonio
    Vivancos, Jose
    Gabriel, Rafael
    MEDICINA CLINICA, 2008, 131 (20): : 765 - 769
  • [30] Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)
    Li, Jian-Jun
    Lu, Zong-Liang
    Kou, Wen-Rong
    Chen, Zuo
    Wu, Yang-Feng
    Yu, Xue-Hai
    Zhao, Yu-Cheng
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (08) : 947 - 956